Ideally a partnership agreement can be made to carry this forward. Looks like the recent BOD appointment was done with this in mind. The more pre-clinical data available will assist in negotiations.
Ann: ATX FAK Inhibitors Reduce Fibrosis in Animal Model of NASH, page-7
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.38M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 13.8¢ | $34.30K | 245.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 65549 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 85150 | 2 |
View Market Depth
| Last trade - 10.57am 20/08/2024 (20 minute delay) ? |
| ATX (ASX) Chart |